Risk of cancer after initiation of targeted therapies in patients with rheumatoid arthritis and a prior cancer: systematic review with meta-analysis.

Amélie WetzmanCédric LukasCécile Gaujoux-VialaRonac MamtaniThomas BarnetcheBernard CombeJacques Morel Paulina Szafors

Published in: Arthritis care & research (2021)

Apart from skin cancers including melanoma, the risk of recurrent or new cancer is not increased with the initiation of bDMARDs for RA as compared with no bDMARDs.

Keyphrases

papillary thyroid
squamous cell
squamous cell carcinoma
systemic lupus erythematosus
ankylosing spondylitis
soft tissue